Lambert, J S <br/><br/>
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218).  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association  Dec 1998 
 - 451-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1077-9450 
<br/><br/><label>Standard No.: </label>10.1097/00042560-199812150-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--administration & dosage<br/>Adolescent<br/>CD4 Lymphocyte Count<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>HIV Envelope Protein gp120--immunology<br/>HIV Envelope Protein gp160--immunology<br/>HIV Infections--immunology<br/>Humans<br/>Immunoenzyme Techniques<br/>Immunotherapy, Active--adverse effects<br/>Infant<br/>Injections, Intramuscular<br/>Lymphocyte Activation<br/>Male<br/>Vaccines, Synthetic--administration & dosage